Crossmark

[177Lu]Lu-EDTMP —a bone pain palliating agent: pharmacokinetics, biodistribution, safety profile and clinical evaluation in osseous metastatic patients

Crossref DOI link: https://doi.org/10.1007/s00259-025-07218-x

Published Online: 2025-04-02

Published Print: 2025-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Saeed, Shabana https://orcid.org/0000-0003-2890-6886
Paez, Diana https://orcid.org/0000-0001-9268-0979
Estrada Lobato, Enrique https://orcid.org/0000-0002-2597-8609
Delgado Bolton, Roberto C. https://orcid.org/0000-0002-8071-6513
Jameel, Ghazal

Qureshi, Farida

Pellet, Olivier

Brink, Anita

Soto, Adrian

Grigoryan, Anna

Knoll, Peter

Giammarile, Francesco https://orcid.org/0000-0002-0550-7893
Funding

Funding for this research was provided by:

International Atomic Energy Agency (E13033)
License Information

Text and Data Mining valid from 2025-04-02

Version of Record valid from 2025-04-02
More Information

Article History

Received: 20 December 2024

Accepted: 10 March 2025

First Online: 2 April 2025

Declarations

:

: The author declared no conflicts of interest.

Document is current

Any future updates will be listed below